Exosens
EXENS.PA · PAR
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | €987 | €608 | €608 | €608 |
| - Cash | €117 | €15 | €29 | €16 |
| + Debt | €11 | €312 | €255 | €208 |
| Enterprise Value | €880 | €904 | €834 | €800 |
| Revenue | €394 | €319 | €201 | €166 |
| % Growth | 23.6% | 58.8% | 20.8% | – |
| Gross Profit | €226 | €177 | €114 | €100 |
| % Margin | 57.2% | 55.5% | 56.8% | 60.2% |
| EBITDA | €115 | €84 | €51 | -€101 |
| % Margin | 29.2% | 26.3% | 25.5% | -60.9% |
| Net Income | €31 | €17 | €11 | -€149 |
| % Margin | 7.8% | 5.4% | 5.6% | -89.6% |
| EPS Diluted | 0.6 | 0.56 | 0.37 | -4.9 |
| % Growth | 7.1% | 51.4% | 107.6% | – |
| Operating Cash Flow | €96 | €50 | €47 | €43 |
| Capital Expenditures | -€41 | -€31 | -€22 | -€20 |
| Free Cash Flow | €96 | €20 | €26 | €23 |